Jim Woody has more than 25 years of pharmaceutical research and management expertise He currently serves as Chairman of Oncomed Pharmaceuticals, where he was previously a founder and CEO; he is also a General Partner at Latterell Venture Partners, a venture capital group focusing on early-stage healthcare companies He has served in a variety of […]

On this week’s Tech Nation, Dr. Jonathan Javitt from NeuroRX Pharma talks about a scientific discovery which lingered for nearly two decades in some 70 boxes in deep storage – it’s now being tested as a treatment for COVID-19. Then Rick Carreon, the CEO of ImpediMed, tells us about a technology developed in the 1990’s […]

Chimeric Antigen Receptor T (CAR-T) cellular therapies allow a patient’s T-cells to be genetically modified to display receptors for tumor cell proteins, leading to binding and destruction. This therapy has come a long way since its inception in the late 1980s by immunologist Zelig Eshharat the Weizmann Institute of Science in Israel. In 2017 the […]